市場調査レポート
商品コード
1429601

医薬品の世界市場レポート 2024年

Pharmaceutical Drugs Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 400 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
医薬品の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 400 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

医薬品の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には13.4%の年間複合成長率(CAGR)で2兆929億5,000万米ドルに成長すると予想されます。予測期間の拡大は、政府支援の増大、医療アクセスの増加、投資の増加、高齢者人口の急速な増加、医療支出の急増、予防接種とワクチン接種に対する意識の高まりに起因すると考えられます。予測期間の主要動向としては、創薬におけるバイオマーカーの使用、次世代生物製剤開発への注目の高まり、個別化医療への重点の集中、創薬のための人工知能(AI)への投資、治療薬の併用療法の採用などが挙げられます。呼吸器疾患、医薬品の研究開発を強化するためのウェアラブル企業との提携、医薬品製造における3Dプリンティング技術の利用、ドラッグデリバリーを改善するためのマイクロニードル錠剤の開発、mRNA技術を使用したワクチン開発の進歩などです。

座りっぱなしの仕事、多忙なライフスタイルの増加、消費者の嗜好の進化は、世界の疾病情勢、特にがん、糖尿病、心血管疾患などの非感染性疾患の蔓延に影響を与えています。長時間労働、身体活動の減少、不健康な食生活などの要因は、糖尿病などの慢性疾患に大きく寄与します。世界保健機関によると、非感染性疾患(NCD)による年間死亡者数は4,100万人で、世界の死亡率の74%を占めています。この傾向は、糖尿病などの症状に対処するための生物学的製剤の需要が高まっていることを裏付けています。これらの要因により世界の患者人口が拡大すると予想され、それによって予測期間を通じて医薬品市場の成長が促進されます。

希少疾患の発生の増加は、将来的に医薬品市場を牽引すると予想されます。希少疾患は、より一般的な健康問題と比較して有病率が低いという特徴があり、人口のほんの一部にのみ影響を及ぼします。 医薬品は、これらの疾患の管理、潜在的な治療法の特定を容易にし、重篤な副作用を伴う不必要な治療を防止する上で重要な役割を果たし、効果的な治療アプローチに貢献します。たとえば、2021年 2月の時点で、国際骨粗鬆症財団(IOF)は、世界中で3億人以上が希少疾患に罹患しており、これは世界人口の3.5%~5.9%を占めていると報告しています。さらに、オーストラリアに本拠を置くデジタルヘルス企業であるヘルス・マッチは、2022年11月に、アメリカと欧州において、罹患率が高く、人口10万人あたり60~80人の発生率を持つ約150の希少な腎臓病を明らかにしました。したがって、希少疾患の発生率の増加は、医薬品市場の成長の触媒として機能します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 製品/サービス分析-製品/サービスの例

  • 医薬品サプライチェーン分析
    • 医薬品のリソース
    • 医薬品のメーカー
    • 医薬品の流通業者と小売業者
    • 医薬品のエンドユーザー
  • 医薬品の顧客情報

第4章 市場動向と戦略

第5章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第6章 世界市場規模と成長

  • 世界の医薬品市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の医薬品市場規模実績と成長、2018~2023年
  • 世界の医薬品市場規模と成長予測、2023~2028年、2033年

第7章 市場セグメンテーション

  • 世界の医薬品市場、タイプ別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 心臓血管の治療薬
  • 皮膚科の治療薬
  • 胃腸薬
  • 生殖器泌尿器の治療薬
  • 血液内科の治療薬
  • 抗感染症薬
  • 代謝異常症の治療薬
  • 筋骨格系疾患の治療薬
  • 中枢神経系の治療薬
  • 世界の医薬品市場、医薬品分類別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • ブランド医薬品
  • ジェネリック医薬品
  • 世界の医薬品市場、投与経路別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 経口
  • 非経口
  • その他
  • 世界の医薬品市場、購入方法別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 処方薬
  • 市販薬
  • 世界の医薬品市場、流通チャネル別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 病院薬局
  • 小売薬局/ドラッグストア
  • その他

第8章 地域と国の分析

  • 世界の医薬品市場、地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の医薬品市場、国別、実績と予測、2018~2023年、2023~2028年、2033年

第9章 アジア太平洋市場

第10章 中国市場

第11章 インド市場

第12章 日本市場

第13章 オーストラリア市場

第14章 インドネシア市場

第15章 韓国市場

第16章 バングラデシュ市場

第17章 タイ市場

第18章 ベトナム市場

第19章 マレーシア市場

第20章 シンガポール市場

第21章 フィリピン市場

第22章 香港市場

第23章 ニュージーランド市場

第24章 西欧市場

第25章 英国市場

第26章 ドイツ市場

第27章 フランス市場

第28章 イタリア市場

第29章 スペイン市場

第30章 オーストリア市場

第31章 ベルギー市場

第32章 デンマーク市場

第33章 フィンランド市場

第34章 アイルランド市場

第35章 オランダ市場

第36章 ノルウェー市場

第37章 ポルトガル市場

第38章 スウェーデン市場

第39章 スイス市場

第40章 東欧市場

第41章 ロシア市場

第42章 チェコ共和国の市場

第43章 ポーランド市場

第44章 ルーマニア市場

第45章 ウクライナ市場

第46章 北米市場

第47章 米国市場

第48章 カナダ市場

第49章 メキシコ市場

第50章 南米市場

第51章 ブラジル市場

第52章 チリ市場

第53章 アルゼンチン市場

第54章 コロンビア市場

第55章 ペルー市場

第56章 中東市場

第57章 サウジアラビア市場

第58章 イスラエル市場

第59章 イラン市場

第60章 トルコ市場

第61章 アラブ首長国連邦市場

第62章 アフリカ市場

第63章 エジプト市場

第64章 ナイジェリア市場

第65章 南アフリカ市場

第66章 競合情勢と企業プロファイル

  • 医薬品市場の競合情勢
  • 医薬品市場の企業プロファイル
    • Pfizer Inc.
    • AbbVie
    • Johnson &Johnson
    • Merck &Co
    • Sanofi SA

第67章 その他の大手と革新的な企業

  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Bristol-Myers Squibb
  • AstraZeneca
  • GlaxosmithKline
  • Shanghai Pharmaceutical Drugs
  • Shanghai Fosun Pharmaceutical
  • Takeda Pharmaceutical Company Ltd.
  • Otsuka Pharmaceutical Co. Ltd.
  • Daiichi Sankyo
  • China National Pharmaceutical Group Co., Ltd.(Sinopharm)
  • Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd.
  • Jiangsu Hengrui Medicine Co., Ltd
  • Hanmi Pharmaceutical
  • Cipla Limited

第68章 競合ベンチマーキング

第69章 競合ダッシュボード

第70章 主要な合併と買収

第71章 将来の展望と潜在性分析

第72章 付録

目次
Product Code: r14572

A pharmaceutical drug is a substance designed for the treatment, prevention, or alleviation of an illness, condition, or its symptoms. These substances can be administered through various methods, including oral consumption, skin patches, injections, or inhalation. Notable pharmaceuticals derived from natural sources encompass vaccinations, steroid hormones, human blood-plasma fractions, and antibiotics.

The primary categories of pharmaceutical drugs cover a wide spectrum, including cardiovascular drugs, dermatology drugs, gastrointestinal drugs, genito-urinary drugs, hematology drugs, anti-infective drugs, metabolic disorders drugs, musculoskeletal disorders drugs, central nervous system drugs, oncology drugs, ophthalmology drugs, and respiratory diseases drugs. Cardiovascular drugs are specifically tailored to address medical conditions related to the heart or circulatory system, such as arrhythmias, blood clots, coronary artery disease, high or low blood pressure, high cholesterol, heart failure, and stroke. These drugs can be administered through various routes, including oral and parenteral methods, and are categorized as branded or generic drugs. The acquisition of pharmaceutical drugs can occur through prescription-based or over-the-counter channels, with distribution taking place through hospital pharmacies, retail pharmacies/drug stores, and other outlets.

The pharmaceutical drug market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical drug market statistics, including pharmaceutical drug industry global market size, regional shares, competitors with a pharmaceutical drug market share, detailed pharmaceutical drug market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical drug industry. This pharmaceutical drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical drugs market size has grown strongly in recent years. It will grow from $1199.86 billion in 2023 to $1267.05 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The expansion in the historical period can be ascribed to an upswing in healthcare awareness, a heightened prevalence of respiratory diseases, shifts in lifestyles, a surge in pharmaceutical research and development (R&D) expenditure, a growing aging population, a rise in the number of surgical procedures, robust economic growth in emerging markets, and an increased number of approvals for hematology/oncology (cancer) drugs.

The pharmaceutical drugs market size is expected to see rapid growth in the next few years. It will grow to $2092.95 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%. The expansion in the forecast period can be attributed to growing government support, an increase in healthcare access, a rise in investments, rapid growth in the elderly population, an upsurge in healthcare expenditure, and heightened awareness of immunization and vaccination. Key trends in the forecast period include the use of biomarkers for drug development, an increased focus on next-generation biologics development, a heightened emphasis on personalized medicine, investments in artificial intelligence (AI) for drug discovery, the adoption of combination drug therapy for respiratory diseases, partnerships with wearables companies to enhance drug research and development, the utilization of 3D printing technology in drug manufacturing, the development of microneedle pills for improved drug delivery, and advancements in vaccine development using mRNA technology.

The increase in sedentary jobs, busy lifestyles, and evolving consumer preferences is impacting the global disease landscape, particularly the prevalence of non-communicable diseases such as cancer, diabetes, and cardiovascular conditions. Factors such as prolonged working hours, reduced physical activity, and unhealthy dietary habits contribute significantly to chronic diseases such as diabetes. According to the World Health Organization, noncommunicable diseases (NCDs) account for 41 million deaths annually, representing 74% of global mortality. This trend underscores the growing demand for biologic drugs to address conditions such as diabetes. These factors are anticipated to expand the global patient population, thereby fostering growth in the pharmaceutical drug market throughout the forecast period.

The escalating occurrence of rare diseases is expected to drive the pharmaceutical drug market in the future. Rare diseases, characterized by low prevalence in comparison to more common health issues, affect only a small percentage of the population. Pharmaceutical drugs play a crucial role in managing these diseases, facilitating the identification of potential therapeutics, and preventing unnecessary treatments with severe side effects, contributing to effective treatment approaches. For instance, as of February 2021, the International Osteoporosis Foundation (IOF) reported that over 300 million people worldwide are affected by rare diseases, constituting 3.5% to 5.9% of the global population. Additionally, in November 2022, Health Match, an Australia-based digital health company, highlighted approximately 150 rare kidney diseases with high prevalence rates, ranging from 60 to 80 incidences per 100,000 people in America and Europe. Hence, the increasing incidence of rare diseases acts as a catalyst for the pharmaceutical drug market's growth.

Leading companies in the pharmaceutical drug market are introducing innovative medications such as Sohonos (palovarotene) capsules to establish a competitive advantage. Sohonos, a retinoid, is designed to reduce the volume of new heterotopic ossification in individuals with fibrodysplasia ossificans progressiva (FOP). For instance, in August 2023, Ipsen Biopharmaceuticals, Inc., a France-based biopharmaceutical company, unveiled Sohonos (palovarotene). This retinoid is indicated for minimizing the volume of new heterotopic ossification in adults and pediatric patients (8 years and older for females, 10 years and older for males) with FOP-a rare genetic disorder characterized by abnormal bone development in areas not typically containing bone, leading to limited movement, deformities, and severe disability.

An emerging trend in the dermatology drugs market is the early Rx-to-OTC switch, where products transition from prescription to non-prescription status. Traditionally, this shift occurred near the drug's patent expiry or afterward. However, forward-thinking companies are now opting for early Rx-to-OTC switches well in advance of patent expiry to capitalize on market opportunities and recover product-related expenses. This strategy offers additional benefits to manufacturers. For instance, in 2020, the FDA approved the switch of three prescription drugs to OTC status, including Voltaren for arthritis pain and olopatadine hydrochloride 0.1% and 0.2% (Pataday Twice Daily Relief and Pataday Once Daily Relief) for temporary relief of itchy and red eyes caused by pollen, ragweed, and grass.

Major companies operating in the pharmaceutical drugs market report are Pfizer Inc., AbbVie, Johnson & Johnson, Merck & Co, Sanofi S.A., F. Hoffmann-La Roche Ltd., Novartis AG, Bristol-Myers Squibb, AstraZeneca, GlaxosmithKline, Shanghai Pharmaceutical Drugs, Shanghai Fosun Pharmaceutical, Takeda Pharmaceutical Company Ltd., Otsuka Pharmaceutical Co. Ltd., Daiichi Sankyo, China National Pharmaceutical Group Co., Ltd. (Sinopharm), Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd., Hanmi Pharmaceutical, Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Sun Pharma, KYORIN Holdings, Inc., Nichi-Iko Pharmaceutical Co., Ltd., Daewoong Pharmaceutical Co.,Ltd., Kalbe Farma, Hyphens Pharma, Adjuvanz Technology Pte Ltd., Alliance Pharm Pte Ltd., Teva UK Limited, Abbott Laboratories, Vectura Group, Boehringer Ingelheim, Mylan, Zentiva, Apotex, Gilead Sciences, Bayer, Amgen, Janssen Pharmaceutica, Accord Healthcare Inc., AA Pharma Inc, Sanfer, LABORATORIOS SENOSIAIN SA DE CV (Senosiain), Siegfried Rhein, Eli Lilly & Company, Biogen, EMS Pharma, Hypermarcas, Eurofarma, Teuto Brasileiro, Biolab Farmaceutica, Cristalia, Uniao Quimica, Ache, Mantecorp Farmasa, Libbs, FQM Grupo, Spimaco, Jamjoom Pharma, Tabuk Pharmaceutical Manufacturing, Jazeera Pharmaceutical Industries, Julphar, Neopharma, Johnson & Johnson, Eurolab, Aspen.

North America was the largest region in the pharmaceutical drugs market in 2023. Middle East is expected to be the fasted growing region in the forecast period. The regions covered in the pharmaceutical drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the pharmaceutical drugs market report are Australia, China, India, Indonesia, Japan, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, France, Germany, UK, Austria, Belgium, Denmark, Finland, Ireland, Italy, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa

The pharmaceutical drug market consists of sales of generic drugs, over-the-counter medications, bulk drugs, vaccines, biosimilars, and biologics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceutical drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1)By Type: Cardiovascular Drugs; Dermatology Drugs; Gastrointestinal Drugs; Genito-Urinary Drugs; Hematology Drugs; Anti-Infective Drugs; Metabolic Disorder Drugs; Musculoskeletal Disorder Drugs; Central Nervous System Drugs; Oncology Drugs; Ophthalmology Drugs; Respiratory Disease Drugs; Vaccine And Therapeutic Nutrients; Minerals
  • 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Other Distribution Channels
  • 3) By Drug Classification: Branded Drugs; Generic Drugs
  • 4) By Mode Of Purchase: Over-The-Counter (OTC) Drugs; Prescription-Based Drugs
  • Sub segments: Anti-Hypertensive Drugs; Hypolipidemic; Anti-Thrombotic; Angina Pectoris; Congestive Heart Failure; Other Drugs For Cardiovascular Diseases (Anti-Arrhythmic And Anti-Anginal Drugs); Acne; Dermatitis; Psoriasis; Other Drugs For Dermatology Diseases; Antacids; Antiulcerants; Antiemetics And Antinauseants; Antidiarrheals; Hormonal Contraceptives; Drugs For Benign Prostatic Hyperplasia; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence; Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics; Blood Products And Anemia; Other Blood Disorder Drugs; Antibiotics; Antivirals; Antifungals; Others (Anthelminthic, Antiprotozoal); Anti-Diabetic Drugs; Anti-Thyroid Drugs; Anti-Obesity; Others; Drugs For Rheumatoid Arthritis; Muscle Relaxants; Other Musculoskeletal Disorders Drugs; Analgesics; Anti-Parkinson Drugs; Anesthetics; Anti-Epileptics; Alzheimer; Other CNS Drugs; Drugs For Lung Cancer; Pancreatic Cancer; Breast Cancer; Prostate Cancer; Ovarian Cancer; Colorectal Cancer; Gastric Cancer; Kidney Cancer; Brain Tumor; Thyroid Cancer; Skin Cancer; Bladder Cancer; Cervical Cancer; Blood Cancer; Others; Antiglaucoma Drugs; Dry Eye Medication; Other Ophthalmology Drugs; Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations; Therapeutic Vaccines And Preventive Vaccines; Electrolytes And Minerals; Vitamins
  • Companies Mentioned: Pfizer Inc.; AbbVie; Johnson & Johnson; Merck & Co; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceutical Drugs Market Characteristics

3. Pharmaceutical Drugs Product/Service Analysis -Product/Service Examples

  • 3.1. Pharmaceutical Drugs Supply Chain Analysis
    • 3.1.1. Pharmaceutical Drugs Resources
    • 3.1.2. Pharmaceutical Drugs Manufacturers
    • 3.1.3. Pharmaceutical Drugs Distributors and Retailers
    • 3.1.4. Pharmaceutical Drugs End Users
  • 3.2. Pharmaceutical Drugs Customer Information

4. Pharmaceutical Drugs Market Trends And Strategies

5. Pharmaceutical Drugs Market - Macro Economic Scenario

  • 5.1. Impact Of High Inflation On The Market
  • 5.2. Ukraine-Russia War Impact On The Market
  • 5.3. COVID-19 Impact On The Market

6. Global Pharmaceutical Drugs Market Size and Growth

  • 6.1. Global Pharmaceutical Drugs Market Drivers and Restraints
    • 6.1.1. Drivers Of The Market
    • 6.1.2. Restraints Of The Market
  • 6.2. Global Pharmaceutical Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 6.3. Global Pharmaceutical Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

7. Pharmaceutical Drugs Market Segmentation

  • 7.1. Global Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiovascular Drugs
  • Dermatology Drugs
  • Gastrointestinal Drugs
  • Genito-Urinary Drugs
  • Hematology Drugs
  • Anti-Infective Drugs
  • Metabolic Disorders Drugs
  • Musculoskeletal Disorders Drugs
  • Central Nervous System Drugs
  • 7.2. Global Pharmaceutical Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Branded Drugs
  • Generic Drugs
  • 7.3. Global Pharmaceutical Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • Other Route Of Administration
  • 7.4. Global Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
  • 7.5. Global Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Other Distribution Channels

8. Pharmaceutical Drugs Market Regional And Country Analysis

  • 8.1. Global Pharmaceutical Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.2. Global Pharmaceutical Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. Asia-Pacific Pharmaceutical Drugs Market

  • 9.1. Asia-Pacific Pharmaceutical Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 9.2. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 9.3. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 9.4. Asia-Pacific Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10. China Pharmaceutical Drugs Market

  • 10.1. China Pharmaceutical Drugs Market Overview
  • 10.2. China Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 10.3. China Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 10.4. China Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

11. India Pharmaceutical Drugs Market

  • 11.1. India Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. India Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. India Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Japan Pharmaceutical Drugs Market

  • 12.1. Japan Pharmaceutical Drugs Market Overview
  • 12.2. Japan Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Japan Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.4. Japan Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Australia Pharmaceutical Drugs Market

  • 13.1. Australia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Australia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Australia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. Indonesia Pharmaceutical Drugs Market

  • 14.1. Indonesia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. Indonesia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. Indonesia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. South Korea Pharmaceutical Drugs Market

  • 15.1. South Korea Pharmaceutical Drugs Market Overview
  • 15.2. South Korea Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. South Korea Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. South Korea Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. Bangladesh Pharmaceutical Drugs Market

  • 16.1. Bangladesh, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 16.2. Bangladesh, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

17. Thailand Pharmaceutical Drugs Market

  • 17.1. Thailand, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 17.2. Thailand, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

18. Vietnam Pharmaceutical Drugs Market

  • 18.1. Vietnam, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 18.2. Vietnam, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

19. Malaysia Pharmaceutical Drugs Market

  • 19.1. Malaysia, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 19.2. Malaysia, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

20. Singapore Pharmaceutical Drugs Market

  • 20.1. Singapore, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 20.2. Singapore, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

21. Philippines Pharmaceutical Drugs Market

  • 21.1. Philippines, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 21.2. Philippines, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

22. Hong kong Pharmaceutical Drugs Market

  • 22.1. Hong Kong, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 22.2. Hong Kong, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

23. New Zealand Pharmaceutical Drugs Market

  • 23.1. New Zealand, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 23.2. New Zealand, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

24. Western Europe Pharmaceutical Drugs Market

  • 24.1. Western Europe Pharmaceutical Drugs Market Overview
  • 24.2. Western Europe Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. Western Europe Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. Western Europe Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. UK Pharmaceutical Drugs Market

  • 25.1. UK Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.2. UK Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. UK Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. Germany Pharmaceutical Drugs Market

  • 26.1. Germany Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.2. Germany Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. Germany Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. France Pharmaceutical Drugs Market

  • 27.1. France Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. France Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. France Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Italy Pharmaceutical Drugs Market

  • 28.1. Italy Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.2. Italy Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Italy Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Spain Pharmaceutical Drugs Market

  • 29.1. Spain Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.2. Spain Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Spain Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Austria Pharmaceutical Drugs Market

  • 30.1. Austria, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 30.2. Austria, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

31. Belgium Pharmaceutical Drugs Market

  • 31.1. Belgium, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 31.2. Belgium, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

32. Denmark Pharmaceutical Drugs Market

  • 32.1. Denmark, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 32.2. Denmark, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

33. Finland Pharmaceutical Drugs Market

  • 33.1. Finland, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 33.2. Finland, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

34. Ireland Pharmaceutical Drugs Market

  • 34.1. Ireland, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 34.2. Ireland, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

35. Netherlands Pharmaceutical Drugs Market

  • 35.1. Netherlands, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 35.2. Netherlands, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

36. Norway Pharmaceutical Drugs Market

  • 36.1. Norway, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 36.2. Norway, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

37. Portugal Pharmaceutical Drugs Market

  • 37.1. Portugal, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 37.2. Portugal, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

38. Sweden Pharmaceutical Drugs Market

  • 38.1. Sweden, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 38.2. Sweden, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

39. Switzerland Pharmaceutical Drugs Market

  • 39.1. Switzerland, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 39.2. Switzerland, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

40. Eastern Europe Pharmaceutical Drugs Market

  • 40.1. Eastern Europe Pharmaceutical Drugs Market Overview
  • 40.2. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 40.3. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 40.4. Eastern Europe Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

41. Russia Pharmaceutical Drugs Market

  • 41.1. Russia Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 41.2. Russia Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 41.3. Russia Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

42. Czech Republic Pharmaceutical Drugs Market

  • 42.1. Czech Republic, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 42.2. Czech Republic, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

43. Poland Pharmaceutical Drugs Market

  • 43.1. Poland, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 43.2. Poland, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

44. Romania Pharmaceutical Drugs Market

  • 44.1. Romania, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 44.2. Romania, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

45. Ukraine Pharmaceutical Drugs Market

  • 45.1. Ukraine, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 45.2. Ukraine, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

46. North America Pharmaceutical Drugs Market

  • 46.1. North America Pharmaceutical Drugs Market Overview
  • 46.2. North America Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 46.3. North America Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 46.4. North America Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

47. USA Pharmaceutical Drugs Market

  • 47.1. USA Pharmaceutical Drugs Market Overview
  • 47.2. USA Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 47.3. USA Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 47.4. USA Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

48. Canada Pharmaceutical Drugs Market

  • 48.1. Canada Pharmaceutical Drugs Market Overview
  • 48.2. Canada Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 48.3. Canada Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 48.4. Canada Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

49. Mexico Pharmaceutical Drugs Market

  • 49.1. Mexico, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 49.2. Mexico, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

50. South America Pharmaceutical Drugs Market

  • 50.1. South America Pharmaceutical Drugs Market Overview
  • 50.2. South America Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 50.3. South America Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 50.4. South America Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

51. Brazil Pharmaceutical Drugs Market

  • 51.1. Brazil Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 51.2. Brazil Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 51.3. Brazil Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

52. Chile Pharmaceutical Drugs Market

  • 52.1. Chile, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 52.2. Chile, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

53. Argentina Pharmaceutical Drugs Market

  • 53.1. Argentina, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 53.2. Argentina, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

54. Colombia Pharmaceutical Drugs Market

  • 54.1. Colombia, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 54.2. Colombia, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

55. Peru Pharmaceutical Drugs Market

  • 55.1. Peru, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 55.2. Peru, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

56. Middle East Pharmaceutical Drugs Market

  • 56.1. Middle East Pharmaceutical Drugs Market Overview
  • 56.2. Middle East Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 56.3. Middle East Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 56.4. Middle East Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

57. Saudi Arabia Pharmaceutical Drugs Market

  • 57.1. Saudi Arabia, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 57.2. Saudi Arabia, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

58. Israel Pharmaceutical Drugs Market

  • 58.1. Israel, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 58.2. Israel, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

59. Iran Pharmaceutical Drugs Market

  • 59.1. Iran, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 59.2. Iran, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

60. Turkey Pharmaceutical Drugs Market

  • 60.1. Turkey, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 60.2. Turkey, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

61. United Arab Emirates Pharmaceutical Drugs Market

  • 61.1. United Arab Emirates, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 61.2. United Arab Emirates, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

62. Africa Pharmaceutical Drugs Market

  • 62.1. Africa Pharmaceutical Drugs Market Overview
  • 62.2. Africa Pharmaceutical Drugs Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 62.3. Africa Pharmaceutical Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 62.4. Africa Pharmaceutical Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

63. Egypt Pharmaceutical Drugs Market

  • 63.1. Egypt, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 63.2. Egypt, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

64. Nigeria Pharmaceutical Drugs Market

  • 64.1. Nigeria, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 64.2. Nigeria, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

65. South Africa Pharmaceutical Drugs Market

  • 65.1. South Africa, Pharmaceutical Drugs Historic Market, 2018 - 2023, $ Billion
  • 65.2. South Africa, Pharmaceutical Drugs Forecast Market, 2018-2023, 2028F, 2033F, $ Billion

66. Pharmaceutical Drugs Market Competitive Landscape And Company Profiles

  • 66.1. Pharmaceutical Drugs Market Competitive Landscape
  • 66.2. Pharmaceutical Drugs Market Company Profiles
    • 66.2.1. Pfizer Inc.
      • 66.2.1.1. Overview
      • 66.2.1.2. Products and Services
      • 66.2.1.3. Strategy
      • 66.2.1.4. Financial Performance
    • 66.2.2. AbbVie
      • 66.2.2.1. Overview
      • 66.2.2.2. Products and Services
      • 66.2.2.3. Strategy
      • 66.2.2.4. Financial Performance
    • 66.2.3. Johnson & Johnson
      • 66.2.3.1. Overview
      • 66.2.3.2. Products and Services
      • 66.2.3.3. Strategy
      • 66.2.3.4. Financial Performance
    • 66.2.4. Merck & Co
      • 66.2.4.1. Overview
      • 66.2.4.2. Products and Services
      • 66.2.4.3. Strategy
      • 66.2.4.4. Financial Performance
    • 66.2.5. Sanofi S.A.
      • 66.2.5.1. Overview
      • 66.2.5.2. Products and Services
      • 66.2.5.3. Strategy
      • 66.2.5.4. Financial Performance

67. Pharmaceutical Drugs Market Other Major And Innovative Companies

  • 67.1. F. Hoffmann-La Roche Ltd.
  • 67.2. Novartis AG
  • 67.3. Bristol-Myers Squibb
  • 67.4. AstraZeneca
  • 67.5. GlaxosmithKline
  • 67.6. Shanghai Pharmaceutical Drugs
  • 67.7. Shanghai Fosun Pharmaceutical
  • 67.8. Takeda Pharmaceutical Company Ltd.
  • 67.9. Otsuka Pharmaceutical Co. Ltd.
  • 67.10. Daiichi Sankyo
  • 67.11. China National Pharmaceutical Group Co., Ltd. (Sinopharm)
  • 67.12. Shanghai Acebright Pharmaceutical Drugs Group Co., Ltd.
  • 67.13. Jiangsu Hengrui Medicine Co., Ltd
  • 67.14. Hanmi Pharmaceutical
  • 67.15. Cipla Limited

68. Global Pharmaceutical Drugs Market Competitive Benchmarking

69. Global Pharmaceutical Drugs Market Competitive Dashboard

70. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market

71. Pharmaceutical Drugs Market Future Outlook and Potential Analysis

  • 71.1 Pharmaceutical Drugs Market In 2028 - Countries Offering Most New Opportunities
  • 71.2 Pharmaceutical Drugs Market In 2028 - Segments Offering Most New Opportunities
  • 71.3 Pharmaceutical Drugs Market In 2028 - Growth Strategies
    • 71.3.1 Market Trend Based Strategies
    • 71.3.2 Competitor Strategies

72. Appendix

  • 72.1. Abbreviations
  • 72.2. Currencies
  • 72.3. Historic And Forecast Inflation Rates
  • 72.4. Research Inquiries
  • 72.5. The Business Research Company
  • 72.6. Copyright And Disclaimer